Details for New Drug Application (NDA): 205904
✉ Email this page to a colleague
NDA 205904 describes DRONEDARONE HYDROCHLORIDE, which is a drug marketed by Lupin and is included in one NDA. Additional details are available on the DRONEDARONE HYDROCHLORIDE profile page.
The generic ingredient in DRONEDARONE HYDROCHLORIDE is dronedarone hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dronedarone hydrochloride profile page.
The generic ingredient in DRONEDARONE HYDROCHLORIDE is dronedarone hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dronedarone hydrochloride profile page.
Summary for 205904
| Tradename: | DRONEDARONE HYDROCHLORIDE |
| Applicant: | Lupin |
| Ingredient: | dronedarone hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 400MG BASE | ||||
| Approval Date: | Jan 31, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
